1. Home
  2. QUAD vs CATX Comparison

QUAD vs CATX Comparison

Compare QUAD & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quad Graphics Inc

QUAD

Quad Graphics Inc

SELL

Current Price

$9.45

Market Cap

438.3M

ML Signal

SELL

Logo Perspective Therapeutics Inc.

CATX

Perspective Therapeutics Inc.

HOLD

Current Price

$2.30

Market Cap

355.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUAD
CATX
Founded
1971
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Publishing
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
438.3M
355.0M
IPO Year
2010
2018

Fundamental Metrics

Financial Performance
Metric
QUAD
CATX
Price
$9.45
$2.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
16
Target Price
★ $13.17
$12.29
AVG Volume (30 Days)
265.7K
★ 2.4M
Earning Date
10-28-2026
11-05-2026
Dividend Yield
★ 4.31%
N/A
EPS Growth
★ 150.47
N/A
EPS
★ 0.13
N/A
Revenue
★ $2,419,900,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$0.06
P/E Ratio
$71.46
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$5.12
$1.96
52 Week High
$11.15
$6.16

Technical Indicators

Market Signals
Indicator
QUAD
CATX
Relative Strength Index (RSI) 48.16 38.38
Support Level $8.96 N/A
Resistance Level $10.42 $3.00
Average True Range (ATR) 0.25 0.19
MACD 0.02 -0.02
Stochastic Oscillator 81.15 16.39

Price Performance

Historical Comparison
QUAD
CATX

About QUAD Quad Graphics Inc

Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America and others countries. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market..

About CATX Perspective Therapeutics Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Share on Social Networks: